Elixa Health’s Vape Story
In early 2015, our team of healthcare and business professionals joined the industry after noticing its rare potential to provide a life saving alternative to cigarettes while creating businesses and economic opportunities for those committing thoroughly to this cause. As government regulations were just beginning at the time, our team worked with proactive companies on manufacturing practices, product testing, and chemical composition research. With the passing of the Deeming Rule and the release of the FDA guidance for the Pre-Market Tobacco Product Application (PMTA), it became clear that many companies would need support to comply with FDA’s regulations. We were fortunate to be able to assist over one hundred companies in compliance with the early FDA submissions: Registration, Product Listing, Ingredient Listing, and Health Documents. In 2020, we completed our most critical project to date by assisting over 30 companies in submitting PMTAs by FDA’s September 2020 deadline. But our journey and our fight for this industry is far from finished, as we know more regulatory scrutiny will be pointed towards the small businesses that we support. We remain fully committed to our mission and our belief that the future of the tobacco industry must include e-vapor products made by small businesses.
“Vaping offers the first acceptable alternative to the leading cause of preventable death in the United States.”